This is amazing news. An individualized melanoma mRNA vaccine demonstrated a 49% reduction in the risk of recurrence or death (HR=0.51; [95% CI, 0.294-0.887]) and a 59% reduction in the risk of distant metastasis or death. Approach is now being tested in many cancers www.merck.com/news/merck-a...